Atlas Trials

Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis

Clinical trial NCT02978183 · COMPLETED

Trial details

NCT number
NCT02978183
Sponsor
Noveome Biotherapeutics, formerly Stemnion
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Allergic Conjunctivitis
Start date
2016-12-01
Primary completion
2017-02-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.